Current report filing

Condensed Consolidated Interim Statement of Loss and Comprehensive Loss (Unaudited)

v3.19.1
Condensed Consolidated Interim Statement of Loss and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue
Expenses:    
Research and development 3,140 1,735
General and administrative 3,702 1,590
Operating Expenses 6,842 3,325
Other income (expense):    
Interest income 44 33
Foreign exchange gains( losses) (16)
Total other income 28 33
Net loss (6,814) (3,292)
Other comprehensive loss:    
Unrealized loss on securities available-for-sale (2)
Total comprehensive loss $ (6,816) $ (3,292)
Basic and diluted loss per common share (in dollars per share) $ (0.23) $ (0.19)
Weighted average number of common shares outstanding used in the calculation of (in thousands) Basic and diluted loss per common share (in shares) 29,042 17,399